echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > The pharmaceutical industry three giant "pits", around the "pit" to live!

    The pharmaceutical industry three giant "pits", around the "pit" to live!

    • Last Update: 2020-07-28
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Guide: What is the current environment for the pharmaceutical industry?What is the current environment for the pharmaceutical industry? The policy of adding to the dividends and dilemmas of the pharmaceutical industry coexistsWith the band procurement, consistency evaluation, medical insurance payment standards and other new medical reform policies intensive introduction of cost-sharing, the market risk of fighting relations gradually enhance the era of pharmaceutical barbarism and spree gradually came to an endIn this new situation, pharmaceutical enterprises are facing the "half is the sea is half the flame" test Author here listed the current most hot three pits suggested that enterprises attach great importance to the pit bypassThe first pit: the special management of medical insurance fund behavior in recent years, the pharmaceutical industry's consolidation efforts continue to strengthen the annual "on strengthening the health planning system wind construction" officially announced according to the document spirit year three-level medical institutions all carry out hospital inspection work year-level medical institutions all carry out hospital inspection workThe Notice of the State Health Insurance Administration and the National Health and Health Commission on the special management work on the standard ization of the use of medical insurance funds by designated medical institutions for medical insurance (Medical Insurance Letter No) requires that the special governance of the illegal use of medical insurance funds by medical insurance fixed-point medical institutions be carried out nationwide in the yearCombined with the relevant policies issued by the relevant provinces, the main governance scope includes super-standard charges, duplicate charges, decomposition charges, serial project charges, inflated medical services, super-medical insurance payment scope (limited) settlement; But in this context there are still enterprises improper thing always feel that the medicine finishing will not be whole to their head always with "can earn a little bit, can give a point" psychology neither return to the product academic itself nor get rid of the gold sales is not in the product clinical value to accelerate the pace is always entangled in "emotional marketing"So like the special management of medical insurance fund behavior is more like a special governance of medical chaos, one of the heavy punches deserves the attention of pharmaceutical enterprisesSecond pit: the volume of procurement from the year "" to the year of the introduction of the joint mining expansion of the volume of procurement policy has brought many very big changes to the pharmaceutical marketFor pharmaceutical companies in the variety selection layout to focus on the key varieties from raw materials and other costs, drug alert system and other quality management to strive to do wellThe next step in band purchasing will be mainly in circulationIt may or will ensure the implementation of the amount of drug production enterprises in the circulation of the interests of the transfer to reduce the price of the winning results will be to establish a reasonable drug price formation mechanismNow the direction of the adoption of market competition methods is mainly to reduce prices but when the formation of reasonable drug prices after the annual centralized procurement will not occur a substantial reduction in the situation of the provinces of the recruitment program will be forced to set the possibility of a decline in the possibility of being replaced by the low procurement price on the basis of independent competition by enterprises, reasonable quotationAlthough the current national health insurance payment standards related policies have not been substantively introduced but the relevant supporting policies are gradually from the "anti-cancer drug price reduction", "imitation drug consistency evaluation of special procurement negotiations" from this point of view in the current transitional period of medical institutions in the balance retention interest stimulus is fully pry the leverage of the standard of medical insurance payment to volume price, to kill the amount of the enthusiasm will not be reducedThe third pit: the drug quality minefield according to the "annual drug quality non-conformity data annual report" shows that the year-on-year total drug quality non-conforming batch decreased the batch of non-conforming batch of Chinese medicine non-conforming batch reduced the batch of non-conforming batch of Chinese medicine reduced batch reduction batch only batchIt can be seen that the overall non-conformity of drug quality has significantly improved the drug enterprises attach great importance to the quality of drugs, the state to strengthen the supervision of drug production to strengthen the supervision of drug quality in increasing efforts to promote the development of high-quality drugsWith the generic consistency evaluation of the orderly promotion of this situation will gradually changeThe future, which does not pass a consistent evaluation, will face the fate of being eliminated by the marketWhether the consistency evaluation is also the historical debt is good or good is to make up the lesson is also to achieve the score or the work itself is a good thing for the source of the originalIn any case, the drug "quality first" is every medicine person must abide by the rules because everything in the face of quality is secondary in the face of no excellent quality what productacademic, market access, sustained growth will be empty wordsOnly quality is the most important thing
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.